Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senate DTC Bill Is Latest Candidate For Inclusion In Bioterrorism Conference

Executive Summary

A Senate Democratic proposal to limit direct-to-consumer advertising is the latest pharmaceutical bill whose sponsors hope to use the bioterrorism conference measure as a vehicle for enactment

You may also be interested in...



FDA Commercial Speech Restrictions Could Hold Up In Court, Agency Says

FDA could still enforce restrictions on commercial speech even in light of the recent Supreme Court decision striking down limits on pharmacy advertising of compounding, FDA Associate Chief Counsel Patricia Kaeding said

FDA Commercial Speech Restrictions Could Hold Up In Court, Agency Says

FDA could still enforce restrictions on commercial speech even in light of the recent Supreme Court decision striking down limits on pharmacy advertising of compounding, FDA Associate Chief Counsel Patricia Kaeding said

PBM Quality Comparisons Feature In Senate Dems’ Medicare Rx Bill

PBMs delivering a drug benefit under Medicare would be subject to quality and consumer satisfaction comparisons under Sen. Bob Graham's (D-Fla.) Medicare Rx bill

Related Content

UsernamePublicRestriction

Register

MT142639

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel